Skip to main content
padlock icon - secure page this page is secure

Free Content Anti-LGI1 Encephalitis: A Case Report of a Recently Described Disease Entity

Download Article:
(HTML 28.2 kb)
(PDF 561.8 kb)
Anti-leucine-rich glioma-inactivated protein 1 encephalitis is a rare disease characterized by autoantibodies to a secreted synaptic protein associated with the voltage-gated potassium channel complex and previously attributed to voltage-gated potassium channel antibodies. The classic clinical presentation is limbic encephalitis with memory loss and pathognomonic faciobrachial dystonic seizures, but patients can also experience paroxysmal dizziness, as well as pain and other symptoms of peripheral nervous system involvement. We present a case of anti‐leucine-rich glioma-inactivated protein 1 encephalitis as a review of the clinical presentation, laboratory findings, and imaging findings, and discuss prognosis with treatment. A brief review of the anti‐leucine-rich glioma-inactivated protein 1 encephalitis literature is also provided.
No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: AMPAR = α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor; FBDS = faciobrachial dystonic seizure; LGI1 = leucine-rich glioma-inactivated protein 1; VGKC = voltage-gated potassium channel

Document Type: Research Article

Publication date: June 1, 2019

More about this publication?
  • Neurographics is the peer-reviewed, bimonthly educational journal of the American Society of Neuroradiology. The journal comprises articles selected from material presented at the ASNR Annual Meeting. Neurographics also publishes other high-quality submissions that are primarily educational and have a high emphasis on a pictorial approach. Neurographics offers CME credit for reading review articles and completing quiz-based self-assessment activities.

    Visit the ASNR Education Connection to view all available CME courses.

  • Editorial Board
  • Information for Authors
  • Membership Information
  • Order a Print Copy
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more